Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the Safety and Efficacy of BOTOX for Forehead and Glabellar Facial Rhytides
2014-001860-36Phase 3Completed
- Sponsor
- Allergan
- Start
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in Rhytidosis facialis and glabellar furrowing, sponsored by Allergan. Started Nov 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Rhytidosis facialisglabellar furrowing
Beyond the preview
Go deeper on 2014-001860-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001860-36.